Antifungal use in immunocompetent, critically ill patients with pneumonia does not improve clinical outcomes
Abstract Purpose To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to presumed colonization. Methods We conducted a retrospective study of immunocompetent, critically ill adult patients from 2010 to...
Saved in:
Published in | Heart & lung Vol. 45; no. 6; pp. 538 - 543 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.11.2016
Elsevier Science Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Purpose To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to presumed colonization. Methods We conducted a retrospective study of immunocompetent, critically ill adult patients from 2010 to 2014. Patients with a BAL culture-positive for Candida or unspeciated yeast and a clinical suspicion of pneumonia were included. The treatment group received an antifungal agent for at least 5 days, and the control group received either no antifungal therapy or an antifungal agent for less than 48 h. Recruitment occurred in a 2:1 ratio of untreated versus treated patients. Results Seventy-five patients were included. In-hospital mortality was similar between treated and untreated groups (24% vs. 26%, P = 0.85). Length of stay and duration of mechanical ventilation also did not differ between the two groups. Conclusion We did not observe a difference in mortality or clinical outcomes in patients treated with antifungal agents. Presumptive antifungal therapy for BAL-positive Candida or yeast in immunocompetent patients did not result in improved clinical outcomes. |
---|---|
AbstractList | To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to presumed colonization.
We conducted a retrospective study of immunocompetent, critically ill adult patients from 2010 to 2014. Patients with a BAL culture-positive for Candida or unspeciated yeast and a clinical suspicion of pneumonia were included. The treatment group received an antifungal agent for at least 5 days, and the control group received either no antifungal therapy or an antifungal agent for less than 48 h. Recruitment occurred in a 2:1 ratio of untreated versus treated patients.
Seventy-five patients were included. In-hospital mortality was similar between treated and untreated groups (24% vs. 26%, P = 0.85). Length of stay and duration of mechanical ventilation also did not differ between the two groups.
We did not observe a difference in mortality or clinical outcomes in patients treated with antifungal agents. Presumptive antifungal therapy for BAL-positive Candida or yeast in immunocompetent patients did not result in improved clinical outcomes.
•Candida from a bronchoalveolar lavage (BAL) culture usually represents colonization.•Antifungal treatment of Candida from a BAL does not improve clinical outcomes.•Not recommended to treat Candida from a BAL in immunocompetent patients. Purpose: To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to presumed colonization. Methods: We conducted a retrospective study of immunocompetent, critically ill adult patients from 2010 to 2014. Patients with a BAL culture-positive for Candida or unspeciated yeast and a clinical suspicion of pneumonia were included. The treatment group received an antifungal agent for at least 5 days, and the control group received either no antifungal therapy or an antifungal agent for less than 48 h. Recruitment occurred in a 2:1 ratio of untreated versus treated patients. Results: Seventy-five patients were included. In-hospital mortality was similar between treated and untreated groups (24% vs. 26%, P = 0.85). Length of stay and duration of mechanical ventilation also did not differ between the two groups. Conclusion: We did not observe a difference in mortality or clinical outcomes in patients treated with antifungal agents. Presumptive antifungal therapy for BAL-positive Candida or yeast in immunocompetent patients did not result in improved clinical outcomes. Abstract Purpose To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to presumed colonization. Methods We conducted a retrospective study of immunocompetent, critically ill adult patients from 2010 to 2014. Patients with a BAL culture-positive for Candida or unspeciated yeast and a clinical suspicion of pneumonia were included. The treatment group received an antifungal agent for at least 5 days, and the control group received either no antifungal therapy or an antifungal agent for less than 48 h. Recruitment occurred in a 2:1 ratio of untreated versus treated patients. Results Seventy-five patients were included. In-hospital mortality was similar between treated and untreated groups (24% vs. 26%, P = 0.85). Length of stay and duration of mechanical ventilation also did not differ between the two groups. Conclusion We did not observe a difference in mortality or clinical outcomes in patients treated with antifungal agents. Presumptive antifungal therapy for BAL-positive Candida or yeast in immunocompetent patients did not result in improved clinical outcomes. PURPOSETo determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to presumed colonization.METHODSWe conducted a retrospective study of immunocompetent, critically ill adult patients from 2010 to 2014. Patients with a BAL culture-positive for Candida or unspeciated yeast and a clinical suspicion of pneumonia were included. The treatment group received an antifungal agent for at least 5 days, and the control group received either no antifungal therapy or an antifungal agent for less than 48 h. Recruitment occurred in a 2:1 ratio of untreated versus treated patients.RESULTSSeventy-five patients were included. In-hospital mortality was similar between treated and untreated groups (24% vs. 26%, P = 0.85). Length of stay and duration of mechanical ventilation also did not differ between the two groups.CONCLUSIONWe did not observe a difference in mortality or clinical outcomes in patients treated with antifungal agents. Presumptive antifungal therapy for BAL-positive Candida or yeast in immunocompetent patients did not result in improved clinical outcomes. To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to presumed colonization. We conducted a retrospective study of immunocompetent, critically ill adult patients from 2010 to 2014. Patients with a BAL culture-positive for Candida or unspeciated yeast and a clinical suspicion of pneumonia were included. The treatment group received an antifungal agent for at least 5 days, and the control group received either no antifungal therapy or an antifungal agent for less than 48 h. Recruitment occurred in a 2:1 ratio of untreated versus treated patients. Seventy-five patients were included. In-hospital mortality was similar between treated and untreated groups (24% vs. 26%, P = 0.85). Length of stay and duration of mechanical ventilation also did not differ between the two groups. We did not observe a difference in mortality or clinical outcomes in patients treated with antifungal agents. Presumptive antifungal therapy for BAL-positive Candida or yeast in immunocompetent patients did not result in improved clinical outcomes. Purpose: To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to presumed colonization. Methods: We conducted a retrospective study of immunocompetent, critically ill adult patients from 2010 to 2014. Patients with a BAL culture-positive for Candida or unspeciated yeast and a clinical suspicion of pneumonia were included. The treatment group received an antifungal agent for at least 5 days, and the control group received either no antifungal therapy or an antifungal agent for less than 48 h. Recruitment occurred in a 2:1 ratio of untreated versus treated patients. Results: Seventy-five patients were included. In-hospital mortality was similar between treated and untreated groups (24% vs. 26%, P = 0.85). Length of stay and duration of mechanical ventilation also did not differ between the two groups. Conclusion: We did not observe a difference in mortality or clinical outcomes in patients treated with antifungal agents. Presumptive antifungal therapy for BAL-positive Candida or yeast in immunocompetent patients did not result in improved clinical outcomes. References |
Author | Huynh, Toan, MD McCurdy, Lewis H., MD Martin, Kelly E., PharmD Templin, Megan A., MPH, MS Kosmisky, Desiree E., PharmD Pasquale, Timothy R., PharmD Griffin, Meagan, PharmD |
Author_xml | – sequence: 1 fullname: Griffin, Meagan, PharmD – sequence: 2 fullname: Kosmisky, Desiree E., PharmD – sequence: 3 fullname: Templin, Megan A., MPH, MS – sequence: 4 fullname: Huynh, Toan, MD – sequence: 5 fullname: McCurdy, Lewis H., MD – sequence: 6 fullname: Pasquale, Timothy R., PharmD – sequence: 7 fullname: Martin, Kelly E., PharmD |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27601213$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk1rFTEUhoNU7G31H4gE3LhwrvmcZDZCKX5BwYW6DpnMmTbXTHKdZFruvzfDbRW60WxCwvO-OSfvOUMnMUVA6CUlW0po-263vZlLiNdbVk9boreEsCdoQyVTDWdan6ANoUI1nWz5KTrLeUfq4q16hk6ZaglllG9QuIjFj0u8tgEvGbCP2E_TEpNL0x4KxPIWu9kX72wIB-xDwHtbfL3P-M6XG7yPsEwpeouHBBnHVKrBfk63gF3wcdXhtJRqB_k5ejrakOHF_X6Ofnz88P3yc3P19dOXy4urxgmlSzP2EtgAUgAZxNjSnsqejERrxoUSvbVdZ4nq204ooqwCJRkVUnDlhKaSOn6O3hx9ax2_FsjFTD47CMFGSEs2VMtWK8I6_h8o75QgWrUVff0I3aVljrWRSglOaoFkpcSRcnPKeYbR7Gc_2flgKDFrcGZnjsGZNThDtKnBVdmre_Oln2D4I3pIqgLvjwDUj7v1MJvsagwOBj-DK2ZI_l8vPDZ4yOcnHCD_7cVkZoj5tg7POju05YRKqflvLjnCCg |
CitedBy_id | crossref_primary_10_1093_jac_dkx347 |
Cites_doi | 10.1007/s00134-006-0422-0 10.1164/ajrccm.156.2.9612023 10.1378/chest.114.1.146 10.1016/j.jbi.2008.08.010 10.1097/CCM.0b013e318287f713 10.1093/ofid/ofu026 10.1007/s00134-009-1482-8 10.1128/AAC.01128-10 10.1007/s00134-004-2316-3 10.1056/NEJM196007142630204 10.1378/chest.129.1.110 10.1186/cc10574 10.1097/QCO.0b013e32834e0680 10.1007/s00134-014-3352-2 10.1016/j.jcrc.2008.01.005 10.1086/421946 10.1093/cid/civ1194 10.1007/s00134-012-2584-2 |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2016 Elsevier Inc. Copyright © 2016 Elsevier Inc. All rights reserved. Copyright Elsevier Science Ltd. Nov-Dec 2016 |
Copyright_xml | – notice: Elsevier Inc. – notice: 2016 Elsevier Inc. – notice: Copyright © 2016 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Science Ltd. Nov-Dec 2016 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ASE FPQ K6X NAPCQ 7X8 |
DOI | 10.1016/j.hrtlng.2016.08.002 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef British Nursing Index British Nursing Index (BNI) (1985 to Present) British Nursing Index Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Nursing & Allied Health Premium British Nursing Index MEDLINE - Academic |
DatabaseTitleList | Nursing & Allied Health Premium MEDLINE - Academic MEDLINE British Nursing Index |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Nursing |
EISSN | 1527-3288 |
EndPage | 543 |
ExternalDocumentID | 4260986221 10_1016_j_hrtlng_2016_08_002 27601213 S0147956316301558 1_s2_0_S0147956316301558 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | 0-6 08R 0R 1 1- 186 1B1 1KJ 1P 1Z5 1~. 1~5 2KS 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 85S 8P AABSN AACTN AAEDT AAIAV AAIKC AAIKJ AAKOC AALMO AALRI AAOAW AAQFI AAQQT AAQXK AAWTL AAXUO AAYJJ ABBQC ABFLS ABLJU ABLVK ABMAC ABMZM ABPIF ABPPZ ABXDB ABYKQ ACBNA ACDAQ ACJTP ACNCT ACRLP ACXZT ADALY ADBBV ADEZE ADIMB AEBSH AEKER AENEX AEVXI AFDAS AFFNX AFKWA AFRHN AFTJW AFXBA AFXIZ AGHFR AGNAY AGUBO AGYEJ AIDBO AIEXJ AIKHN AISVY AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AZFZN B-7 BEEDS BKOJK BLXMC BNPGV C45 CAG COF COPKO DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 ET EX3 F5P FAFAN FDB FEDTE FGOYB FIRID FNPLU FO G- G-Q GBLVA GJ HVGLF HZ H~9 H~W IHE IPNFZ J1W K K-O K78 KOM L7B LCYCR M M41 MO0 N9A NAHTW NEJ O-L O9- OAUVE OEN OMK ONC ONOOK OVD OZT P-8 P-9 P2P PC. PQEST PQQKQ Q38 QZG R2- RIG ROL RPZ SDF SDG SDP SEL SES SEW SJN SNC SND SNG SPCBC SSH SSZ T5K TEORI TWZ UHS UKR UV1 VQP VVN WH7 WOQ WOW XZL YCJ YQJ YSQ YYQ YZZ Z5R ZCG ZGI ZKG ZUP ZXP --K --M -ET .1- .FO .GJ .~1 0R~ 1P~ 8P~ AAEDW AAMNW ABJNI ADMUD AXJTR EFLBG FYGXN HZ~ ~G- AAXKI AFCTW AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION ASE FPQ K6X NAPCQ 7X8 |
ID | FETCH-LOGICAL-c478t-fb5e2de54e0d4f61b15b0f08823474baa99a07b694707a7e752145437c48151c3 |
IEDL.DBID | AIKHN |
ISSN | 0147-9563 |
IngestDate | Sat Aug 17 01:33:46 EDT 2024 Fri Aug 16 23:07:34 EDT 2024 Fri Sep 13 06:40:37 EDT 2024 Thu Sep 26 15:40:11 EDT 2024 Sat Sep 28 08:07:22 EDT 2024 Fri Feb 23 02:28:17 EST 2024 Thu Aug 18 18:35:43 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Bronchoscopy Pneumonia Yeast Candida Antifungal agents |
Language | English |
License | Copyright © 2016 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c478t-fb5e2de54e0d4f61b15b0f08823474baa99a07b694707a7e752145437c48151c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ORCID | 0000-0003-2697-886X |
PMID | 27601213 |
PQID | 1843008806 |
PQPubID | 47654 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1856870293 proquest_miscellaneous_1839740876 proquest_journals_1843008806 crossref_primary_10_1016_j_hrtlng_2016_08_002 pubmed_primary_27601213 elsevier_sciencedirect_doi_10_1016_j_hrtlng_2016_08_002 elsevier_clinicalkeyesjournals_1_s2_0_S0147956316301558 |
PublicationCentury | 2000 |
PublicationDate | 2016-11-01 |
PublicationDateYYYYMMDD | 2016-11-01 |
PublicationDate_xml | – month: 11 year: 2016 text: 2016-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: St. Louis |
PublicationTitle | Heart & lung |
PublicationTitleAlternate | Heart Lung |
PublicationYear | 2016 |
Publisher | Elsevier Inc Elsevier Science Ltd |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Science Ltd |
References | Wisplinghoff, Bischoff, Tallent (bib1) 2004; 39 Harris, Taylor, Thielke, Payne, Gonzalez, Conde (bib10) 2009 Apr; 42 Lortholary, Desnos-Ollivier, Sitbon (bib9) 2011; 55 Albert, Williamson, Muscedere (bib13) 2014; 40 Rello, Esandi, Diaz (bib5) 1998; 114 Meersseman, Lagrou, Spriet (bib3) 2009; 35 Azoulay, Cohen, Zahar (bib7) 2004; 30 Muskett, Shahin, Eyres (bib14) 2011; 15 Nseir, Jozefowicz, Cavestri (bib18) 2007; 33 Hamet, Pavon, Dalle (bib16) 2012; 38 Azoulay, Timsit, Tafflet (bib17) 2006; 129 Anada-Rajah, Slavin, Thursky (bib8) 2012; 25 Pappas, Kauffman, Andes (bib6) 2016; 62 Delisle, Williamson, Perreault (bib12) 2008; 23 El-Ebiary, Torres, Fabregas (bib4) 1997; 156 Baum (bib2) 1960; 263 Schnabel, Linssen, Guion (bib11) 2014; 1 Raman, Nailor, Nicolau (bib15) 2013; 41 Rello (10.1016/j.hrtlng.2016.08.002_bib5) 1998; 114 Delisle (10.1016/j.hrtlng.2016.08.002_bib12) 2008; 23 Nseir (10.1016/j.hrtlng.2016.08.002_bib18) 2007; 33 Anada-Rajah (10.1016/j.hrtlng.2016.08.002_bib8) 2012; 25 Wisplinghoff (10.1016/j.hrtlng.2016.08.002_bib1) 2004; 39 Muskett (10.1016/j.hrtlng.2016.08.002_bib14) 2011; 15 Raman (10.1016/j.hrtlng.2016.08.002_bib15) 2013; 41 Lortholary (10.1016/j.hrtlng.2016.08.002_bib9) 2011; 55 Baum (10.1016/j.hrtlng.2016.08.002_bib2) 1960; 263 Azoulay (10.1016/j.hrtlng.2016.08.002_bib17) 2006; 129 Pappas (10.1016/j.hrtlng.2016.08.002_bib6) 2016; 62 El-Ebiary (10.1016/j.hrtlng.2016.08.002_bib4) 1997; 156 Meersseman (10.1016/j.hrtlng.2016.08.002_bib3) 2009; 35 Harris (10.1016/j.hrtlng.2016.08.002_bib10) 2009; 42 Schnabel (10.1016/j.hrtlng.2016.08.002_bib11) 2014; 1 Azoulay (10.1016/j.hrtlng.2016.08.002_bib7) 2004; 30 Hamet (10.1016/j.hrtlng.2016.08.002_bib16) 2012; 38 Albert (10.1016/j.hrtlng.2016.08.002_bib13) 2014; 40 |
References_xml | – volume: 156 start-page: 583 year: 1997 end-page: 590 ident: bib4 article-title: Significance of isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients publication-title: Am J Respir Crit Care Med contributor: fullname: Fabregas – volume: 1 start-page: 1 year: 2014 end-page: 6 ident: bib11 article-title: Candida pneumonia in intensive care unit? publication-title: Open Forum Infect Dis contributor: fullname: Guion – volume: 15 start-page: R287 year: 2011 ident: bib14 article-title: Risk factors for invasive fungal disease in critically ill adult patients; a systematic review publication-title: Crit Care contributor: fullname: Eyres – volume: 35 start-page: 1526 year: 2009 end-page: 1531 ident: bib3 article-title: Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study publication-title: Intensive Care Med contributor: fullname: Spriet – volume: 55 start-page: 532 year: 2011 end-page: 538 ident: bib9 article-title: Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2441 patients publication-title: Antimicrob Agents Chemother contributor: fullname: Sitbon – volume: 38 start-page: 1272 year: 2012 end-page: 1279 ident: bib16 article-title: spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia publication-title: Intensive Care Med contributor: fullname: Dalle – volume: 62 start-page: e1 year: 2016 end-page: e50 ident: bib6 article-title: Clinical practice guidelines for the management of candidiasis: 2016 update by the Infectious Diseases Society of America publication-title: Clin Infect Dis contributor: fullname: Andes – volume: 129 start-page: 110 year: 2006 end-page: 117 ident: bib17 article-title: Candida colonization of the respiratory tract and subsequent Pseudomonas ventilator-associated pneumonia publication-title: Chest contributor: fullname: Tafflet – volume: 25 start-page: 107 year: 2012 end-page: 115 ident: bib8 article-title: The case for antifungal stewardship publication-title: Curr Opin Infect Dis contributor: fullname: Thursky – volume: 42 start-page: 377 year: 2009 Apr end-page: 381 ident: bib10 article-title: Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support publication-title: J Biomed Inf contributor: fullname: Conde – volume: 114 start-page: 146 year: 1998 end-page: 149 ident: bib5 article-title: The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients publication-title: Chest contributor: fullname: Diaz – volume: 41 start-page: 1656 year: 2013 end-page: 1663 ident: bib15 article-title: Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures publication-title: Crit Care Med contributor: fullname: Nicolau – volume: 39 start-page: 309 year: 2004 end-page: 317 ident: bib1 article-title: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study publication-title: Clin Infect Dis contributor: fullname: Tallent – volume: 23 start-page: 11 year: 2008 end-page: 17 ident: bib12 article-title: The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients publication-title: J Crit Care contributor: fullname: Perreault – volume: 30 start-page: 1384 year: 2004 end-page: 1389 ident: bib7 article-title: Practices in non-neutropenic ICU patients with Candida-positive airway specimens publication-title: Intensive Care Med contributor: fullname: Zahar – volume: 263 start-page: 70 year: 1960 end-page: 73 ident: bib2 article-title: The significance of publication-title: N Eng J Med contributor: fullname: Baum – volume: 33 start-page: 137 year: 2007 end-page: 142 ident: bib18 article-title: Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study publication-title: Intensive Care Med contributor: fullname: Cavestri – volume: 40 start-page: 1313 year: 2014 end-page: 1322 ident: bib13 article-title: Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study) publication-title: Intensive Care Med contributor: fullname: Muscedere – volume: 33 start-page: 137 issue: 1 year: 2007 ident: 10.1016/j.hrtlng.2016.08.002_bib18 article-title: Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study publication-title: Intensive Care Med doi: 10.1007/s00134-006-0422-0 contributor: fullname: Nseir – volume: 156 start-page: 583 year: 1997 ident: 10.1016/j.hrtlng.2016.08.002_bib4 article-title: Significance of isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.156.2.9612023 contributor: fullname: El-Ebiary – volume: 114 start-page: 146 year: 1998 ident: 10.1016/j.hrtlng.2016.08.002_bib5 article-title: The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients publication-title: Chest doi: 10.1378/chest.114.1.146 contributor: fullname: Rello – volume: 42 start-page: 377 issue: 2 year: 2009 ident: 10.1016/j.hrtlng.2016.08.002_bib10 article-title: Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support publication-title: J Biomed Inf doi: 10.1016/j.jbi.2008.08.010 contributor: fullname: Harris – volume: 41 start-page: 1656 year: 2013 ident: 10.1016/j.hrtlng.2016.08.002_bib15 article-title: Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures publication-title: Crit Care Med doi: 10.1097/CCM.0b013e318287f713 contributor: fullname: Raman – volume: 1 start-page: 1 issue: 1 year: 2014 ident: 10.1016/j.hrtlng.2016.08.002_bib11 article-title: Candida pneumonia in intensive care unit? publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofu026 contributor: fullname: Schnabel – volume: 35 start-page: 1526 year: 2009 ident: 10.1016/j.hrtlng.2016.08.002_bib3 article-title: Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study publication-title: Intensive Care Med doi: 10.1007/s00134-009-1482-8 contributor: fullname: Meersseman – volume: 55 start-page: 532 issue: 2 year: 2011 ident: 10.1016/j.hrtlng.2016.08.002_bib9 article-title: Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2441 patients publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01128-10 contributor: fullname: Lortholary – volume: 30 start-page: 1384 year: 2004 ident: 10.1016/j.hrtlng.2016.08.002_bib7 article-title: Practices in non-neutropenic ICU patients with Candida-positive airway specimens publication-title: Intensive Care Med doi: 10.1007/s00134-004-2316-3 contributor: fullname: Azoulay – volume: 263 start-page: 70 year: 1960 ident: 10.1016/j.hrtlng.2016.08.002_bib2 article-title: The significance of Candida species in human sputum publication-title: N Eng J Med doi: 10.1056/NEJM196007142630204 contributor: fullname: Baum – volume: 129 start-page: 110 year: 2006 ident: 10.1016/j.hrtlng.2016.08.002_bib17 article-title: Candida colonization of the respiratory tract and subsequent Pseudomonas ventilator-associated pneumonia publication-title: Chest doi: 10.1378/chest.129.1.110 contributor: fullname: Azoulay – volume: 15 start-page: R287 year: 2011 ident: 10.1016/j.hrtlng.2016.08.002_bib14 article-title: Risk factors for invasive fungal disease in critically ill adult patients; a systematic review publication-title: Crit Care doi: 10.1186/cc10574 contributor: fullname: Muskett – volume: 25 start-page: 107 year: 2012 ident: 10.1016/j.hrtlng.2016.08.002_bib8 article-title: The case for antifungal stewardship publication-title: Curr Opin Infect Dis doi: 10.1097/QCO.0b013e32834e0680 contributor: fullname: Anada-Rajah – volume: 40 start-page: 1313 year: 2014 ident: 10.1016/j.hrtlng.2016.08.002_bib13 article-title: Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study) publication-title: Intensive Care Med doi: 10.1007/s00134-014-3352-2 contributor: fullname: Albert – volume: 23 start-page: 11 year: 2008 ident: 10.1016/j.hrtlng.2016.08.002_bib12 article-title: The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients publication-title: J Crit Care doi: 10.1016/j.jcrc.2008.01.005 contributor: fullname: Delisle – volume: 39 start-page: 309 year: 2004 ident: 10.1016/j.hrtlng.2016.08.002_bib1 article-title: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study publication-title: Clin Infect Dis doi: 10.1086/421946 contributor: fullname: Wisplinghoff – volume: 62 start-page: e1 issue: 4 year: 2016 ident: 10.1016/j.hrtlng.2016.08.002_bib6 article-title: Clinical practice guidelines for the management of candidiasis: 2016 update by the Infectious Diseases Society of America publication-title: Clin Infect Dis doi: 10.1093/cid/civ1194 contributor: fullname: Pappas – volume: 38 start-page: 1272 year: 2012 ident: 10.1016/j.hrtlng.2016.08.002_bib16 article-title: Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia publication-title: Intensive Care Med doi: 10.1007/s00134-012-2584-2 contributor: fullname: Hamet |
SSID | ssj0000367 |
Score | 2.156498 |
Snippet | Abstract Purpose To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not... To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due to... Purpose: To determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating... PURPOSETo determine if treating bronchoalveolar lavage (BAL) culture-positive patients with antifungal therapy impacted mortality compared to not treating due... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 538 |
SubjectTerms | Adult Antifungal agents Antifungal Agents - therapeutic use Bronchoscopy Candida Cardiovascular Clinical outcomes Critical Care Critical Illness Drug therapy Female Fungal infections Hospital Mortality - trends Hospitalization Humans Immunocompromised Host Immunology Male Middle Aged Mortality Pneumonia Pneumonia, Ventilator-Associated - drug therapy Pneumonia, Ventilator-Associated - microbiology Pneumonia, Ventilator-Associated - mortality Prognosis Pulmonary/Respiratory Respiration, Artificial - adverse effects Retrospective Studies United States - epidemiology Yeast |
Title | Antifungal use in immunocompetent, critically ill patients with pneumonia does not improve clinical outcomes |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0147956316301558 https://dx.doi.org/10.1016/j.hrtlng.2016.08.002 https://www.ncbi.nlm.nih.gov/pubmed/27601213 https://www.proquest.com/docview/1843008806/abstract/ https://search.proquest.com/docview/1839740876 https://search.proquest.com/docview/1856870293 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61W4G4VKW8lpbKSBxJ14lfyXFVtVpA7YlKvVm214GgKFk1yYELvx3PxmlBqCBxy8OxnfF45pP9zRjgnQuoQTBTJtYUNOGpN4l1mUrK3GZUhCtZYrzz5ZVcXfOPN-JmB86mWBikVUbbP9r0rbWOTxZRmotNVS2QlqQCumcBUaDjz3dhL7gjzmewt_zwaXV1b5CZHKOmOe5WSjZF0G1pXl9v-7r5ghwveTryKh_yUA8h0K0nujiA_QghyXLs5VPY8c0hPL6Mm-SH8CiuADyDeolUoDCdQ_Gh86RqSIXxIK2LaLl_T1w866D-Tqq6JjHPakdwgZZsGj8EPa0MWbe-I03bhwpwFcKTKaSStEMfqvPdc7i-OP98tkri8QqJ4yrvk9IKn6294J6ueSlTmwpLS4TcjCtujSkKQ5WVBVdUGeWVwKzmnCmHCV5Sx17ArGkb_wqIcMbnlkubFzk3ojTW2CIzyklD14a7OSSTSPVmzKKhJ3rZNz0OgcYh0HgmJs3moCa56-l3gk3zXZxgnU51l2mq_1CCX7_8TY90cBH_aPN4GmB930zOWUBJOZVzeHv3OsxA3FYxjW8HLBMwHcfUfn8rI2SwjAFbzeHlqDx3gsiQlpSl7PV_d_0InuDdGCJ5DLP-dvBvAlbq7Qnsnv5IT-KM-AlPdhRQ |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIh4XBOW1UMBIHEnXSfxIjlVFtUC3p1bqzbK9DgRFyarJHrjw25nZOC0IFSRuUeLYzng8_mJ_MwPwziNqkLmtEmdLnog02MT5TCdV4TIu8UpV5O-8PFWLc_HpQl7swNHkC0O0ymj7R5u-tdbxzjxKc76u6znRkjSi-xwRBS38xS24TXCe8jcc_LjmeaCJHn2mBZ1Vqnzyn9uSvL5eDk37hRhe6mBkVd60Pt2EP7fr0PFDeBABJDsc-_gIdkK7B3eX8Yh8D-7E___H0BwSEQgnMxbf9IHVLavJG6TzESsP75mPmQ6a76xuGhajrPaMtmfZug0b1NLaslUXetZ2A1ZAexCBTQ6VrNsMWF3on8D58Yezo0USkyskXuhiSConQ7YKUgS-EpVKXSodrwhw50ILZ21ZWq6dKoXm2uqgJcU0F7n2FN4l9flT2G27NjwHJr0NhRPKFWUhrKyss67MrPbK8pUVfgbJJFKzHmNomIlc9s2MQ2BoCAxlxOTZDPQkdzN9Dlq00Mfp1ZvU9Jnh5g8V-PXN37TI4ALxjzb3pwE2180UIkeMVHA1g7dXj3H-0aGKbUO3oTKI6AQF9vtbGanQLiKymsGzUXmuBJERKSlL8xf_3fU3cG9xtjwxJx9PP7-E-_RkdJbch93hchNeIWoa3OvtrPgJtHYVHg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antifungal+use+in+immunocompetent%2C+critically+ill+patients+with+pneumonia+does+not+improve+clinical+outcomes&rft.jtitle=Heart+%26+lung&rft.au=Griffin%2C+Meagan&rft.au=Kosmisky%2C+Desiree+E&rft.au=Templin%2C+Megan+A&rft.au=Huynh%2C+Toan&rft.date=2016-11-01&rft.pub=Elsevier+Science+Ltd&rft.issn=0147-9563&rft.eissn=1527-3288&rft.volume=45&rft.issue=6&rft.spage=538&rft_id=info:doi/10.1016%2Fj.hrtlng.2016.08.002&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=4260986221 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0147-9563&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0147-9563&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0147-9563&client=summon |